Recombinant bovine alkaline fibroblast growth factor eye drops

The invention discloses recombinant bovine alkaline fibroblast growth factor eye drops and a preparation method thereof. The recombinant bovine alkaline fibroblast growth factor eye drops are prepared from the following components by weight: 1500-2500 IU of recombinant bovine alkaline fibroblast gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JIANG RUOFENG, HUANG XIANKE, FANG HAIZHOU, QU WEI, ZHENG ZANSHUN, ZHU AITANG, TAN JIAJIA, ZHENG MEIQUN, LAN XUAN
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses recombinant bovine alkaline fibroblast growth factor eye drops and a preparation method thereof. The recombinant bovine alkaline fibroblast growth factor eye drops are prepared from the following components by weight: 1500-2500 IU of recombinant bovine alkaline fibroblast growth factor, 0.04-0.12mg of human albumin, 2.0-6.0mg of polyvinyl alcohol, 4.0-6.0mg of sodium chloride, 0.20-0.30mg of disodium hydrogen phosphate, 0.40-0.50mg of sodium dihydrogen phosphate and 0.4ml of water for injection. According to the recombinant bovine alkaline fibroblast growth factor eye drops disclosed by the invention, the dosage of auxiliary material is reduced in the eye drops, the stability of the eye drops is also ensured, the shelf life of the eye drops is prolonged, and the application range is enlarged; without the addition of a bacteriostatic agent, the potential risk caused by the bacteriostatic agent and the toxic or side effect to eyes are prevented, and the irritation of the eye drops to eyes is reduced, and the eye drops are safe in use and high in compliance of a patient.